Research Methodologist – BC Cancer

/0 Comments/in , /by
The Regulatory Science Lab is recruiting for a Research Methodologist. In this role, you will have an opportunity to generate RWE to directly inform policy and practice. For full details and to apply online visit: https://jobs.phsa.ca/job/vancouver/research-methodologist-bc-cancer-vancouver/909/68464627152 The Methodologist, Cancer Control Research reports to the Principal Investigator of Cancer Control Research (more…)

Accepting Applications: McGill University, Gerald Bronfman Department of Oncology – Clinician Scientist

/0 Comments/in , /by
The Gerald Bronfman Department of Oncology is seeking applications for the position of a full-time Clinician-Scientist at the rank of Associate or Full Professor (Tenure Track) which will be based at the MUHC in the Division of Medical Oncology.  The Faculty of Medicine and Health Sciences will support the successful (more…)

Saskatchewan Cancer Agency – Manager, Early Detection

/0 Comments/in , /by
For Full Details or to apply online visit: https://www.saskjobs.ca/jsp/joborder/detail.jsp?job_order_id=1367014 Description Position #: 079738 Union: Out of Scope Bargaining Unit: OOS – Saskatchewan Cancer Agency City/Town: Regina Department: Population Health Screening Program for Colorectal Cancer Type: Full-time Regular Expected Start Date: August 27, 2024 Salary: $39.3015 to $57.6487 (Includes compression adjustment) (more…)

CPAC is Hiring : Analyst, Partner Services

/0 Comments/in , /by
Position:           Analyst, Partner Services Reports to:     Manager, Finance and Partner Funding Location: Hybrid. The Partnership’s head office is in downtown Toronto. Candidates can work anywhere in Canada. Job Level: Level 6 salary range: $80,624 – $109,080 per year; Compensation offered will be based on an assessment of the candidate’s (more…)

BioCanRx: 2024 Open Call for Research Proposals

/0 Comments/in , /by
For full details visit: https://biocanrx.com/research/research-program/open-call-2024 BioCanRx, Canada’s Immunotherapy Network, is pleased to announce the launch of its first Open Call for Research Proposals made possible by funding from the Strategic Science Fund. Through this call for proposals, BioCanRx will support multi-disciplinary cancer immunotherapy and biotherapeutic approaches. Key Dates: Call launch: (more…)

Current Oncology News and Info – July 2024

/0 Comments/in , /by
We are happy to help share the latest Current Oncology Society Newsletter outlining some key important updates relevant to the ARCC Community. Download PDF Version. Key Highlights:  Updated 2024 Impact Factor; CO is pleased to receive an increased Impact Factor of 2.8 in the 2023 Journal Citation Reports™ released by (more…)

Have your say: National Lung Cancer Action Plan

/0 Comments/in , /by
Did you know that lung cancer is the leading cause of cancer-related death in Canada? In 2024, it is estimated that 32,100 Canadians will be diagnosed with lung and bronchus cancer, which represents 13% of all new cancer cases. In collaboration with experts across Canada, the Canadian Cancer Society is (more…)

Ontario Health – Decision Scientist

/0 Comments/in , /by
Click here for full details or to Apply Online Posted: April 19, 2024 Want to make a difference in your career?  Consider this opportunity.  The Decision Scientist will be part of the Quality Measurement and Evaluation Team working in partnership with Clinical Cancer Programs, Integrated Diagnostics and Genetics, and the (more…)

2025 Terry Fox New Investigator Award Competition

/0 Comments/in , /by
Value: Up to $150,000/year for 3 years. Registration of intent due: June 3, 2024. Full applications due: August 5, 2024. Click Here for full details and to apply online Purpose To support outstanding new researchers as they develop their careers as independent research scientists or clinician scientists. These awards enable recipients (more…)

New Publication: Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration

/0 Comments/in , /by
The CanREValue Collaboration is excited to share our latest publication – Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration An online version of this paper is available (more…)